Knee · Hip · Rheumatoid arthritis · Istanbul

Stem Cell Therapy for Rheumatoid Arthritis & Osteoarthritis in Istanbul

Stem cell therapy for knee arthritis, hip arthritis and rheumatoid arthritis with fresh Wharton’s jelly stem cells: a non-surgical treatment that calms joint inflammation, eases pain and helps you move more freely. In a 261-patient phase III trial, a single stem cell knee injection relieved pain significantly more than placebo, and in a two-year trial it helped protect cartilage on MRI.123 Treatment takes place in Istanbul, Turkey, under Uzm. Dr. Cihan Bolat.

Close-up of an older woman's hands holding a warm mug of tea on a blue tablecloth
What we use
Fresh Wharton’s jelly stem cells
How
An injection into the joint, no surgery
For
Knee and hip osteoarthritis, rheumatoid arthritis
First changes
Less pain from 3 months in clinical studies
In Istanbul
One treatment day, free transport
Price
Fixed and all-inclusive, in writing

Non-surgical · Knee, hip and other joints · Free medical review

01

Stem cell therapy for arthritis: what it is and how it helps

Stem cell therapy for arthritis uses fresh mesenchymal stem cells (MSCs) from Wharton’s jelly, the soft tissue of donated umbilical cords. Injected into the painful joint, the cells release signals that calm inflammation, protect cartilage and support the joint’s own repair processes.3334

Less pain, easier movement, no surgery

In osteoarthritis, the cartilage that cushions the joint wears down and the joint lining becomes inflamed. In rheumatoid arthritis, the immune system attacks the joints. Stem cells act on both: in clinical trials, patients had less pain, less stiffness and better function, and walked further without pain.125

A non-surgical option to try first

Many people come to us when painkillers, physiotherapy or injections no longer help enough and they would rather avoid or delay joint replacement surgery. In a two-year placebo-controlled trial, 1 patient treated with stem cells needed a knee replacement, against 4 in the placebo group.3

Results at a glance

  • 25.2points of improvement in knee pain (0–100 scale) six months after one injection, against 15.5 with placebo1
  • 68%of patients reported treatment success, against 53% with placebo5
  • 1 vs 4knee replacements over two years with stem cells vs placebo3
  • 5 yearsof maintained benefit in rheumatoid arthritis after umbilical cord stem cells24
From published clinical studies; the small numbers link to each study.

02

How stem cells help your joints

Mesenchymal stem cells work mainly through what researchers call a “hit-and-run” effect: they release signalling molecules and exosomes that calm inflammation and support repair, and these effects continue after the cells themselves have gone.33 Six effects explain the results seen in studies.

How stem cell therapy works in the joint

  1. Fresh stem cellsInjected into the painful joint.
  2. Calming signalsAnti-inflammatory messengers and exosomes.3334
  3. A calmer, protected jointLess inflammation in the joint lining and less cartilage breakdown.172
  4. Less pain, easier movementBetter pain and function scores in randomised trials.14
Illustrated model of a knee joint with the smooth grey cartilage that covers the ends of the bones
Cartilage covers the ends of the bones in the knee. Stem cells help calm inflammation in the joint and protect this cartilage.
  1. Calming joint inflammation

    In knee osteoarthritis, stem cell injections reduced inflammatory immune cells and the inflammatory messenger IL-12 in the joint fluid, and lessened inflammation of the joint lining on MRI.1719 Blood markers of inflammation fell and the calming signal IL-10 rose.18

  2. Protecting cartilage

    In a two-year placebo-controlled trial, patients treated with stem cells showed less breakdown of cartilage collagen and no worsening of cartilage quality on MRI, while cartilage in the placebo group gradually worsened.23 Another trial found better cartilage quality on MRI.16

  3. Turning immune cells into healers

    Stem cells and their exosomes help shift the joint’s immune cells (macrophages) from an inflammatory to a healing “M2” state. In laboratory and animal studies, they helped cartilage cells multiply and build new matrix.343738

  4. Easing pain

    Stem cells calm the inflammatory signals that make pain nerves in the joint over-sensitive, a pain-relieving effect described in research reviews and shown in animal studies.36

  5. Rebalancing the immune system

    In rheumatoid arthritis, umbilical cord stem cell infusions lowered the inflammatory messengers TNF-α and IL-6 and increased regulatory T cells, the immune cells that keep autoimmunity in check.2223

  6. Donor cells the body accepts

    Wharton’s jelly stem cells carry very few of the markers that trigger rejection, which is why donor cells can be used without donor matching.35

03

Our stem cell arthritis treatment in Istanbul

Fresh Wharton’s jelly (umbilical cord) stem cells

Our stem cells come from Wharton’s jelly, collected from umbilical cords donated after healthy births, so nothing is taken from you. We prepare them fresh for your treatment date and never freeze them. They are prepared in a laboratory approved by the Turkish Ministry of Health and certified to GMP standards, with cell count and viability checked before every treatment.

The right dose, not the maximum dose

Positive umbilical cord trials used 5 to 100 million stem cells per knee, and moderate doses of about 20 to 50 million worked best.42021 Your plan states your exact cell count in writing.

1. Into the joint

Fresh stem cells are injected directly into the affected knee, hip or other joint, the route used in the knee trials.124

2. Rheumatoid arthritis

In most rheumatoid arthritis studies, umbilical cord stem cells were given by IV drip alongside the usual medication.2223 Dr. Cihan Bolat plans the right route for your joints.

3. One treatment day

Your treatment is given in one visit. Our driver picks you up, takes you to the clinic and brings you back afterwards.

4. A second dose

In the Wharton’s jelly trial, a second dose at six months gave the best results, and a review of 16 trials found repeat injections improved pain and function more.48

Your comfort: the injection is minimally invasive and given under sterile conditions. Dr. Cihan Bolat, a specialist in anaesthesiology and reanimation, plans your comfort with you, and you walk out the same day.

04

Does stem cell therapy work for knee arthritis? What clinical trials show

Clinical trials measure arthritis with pain scales and the WOMAC score for pain, stiffness and function. The largest trials reported clear gains with stem cells:

Knee osteoarthritis: stem cells vs placebo

Improvement in knee pain after 6 months (0–100 scale)1

25.2 points with stem cells
15.5 points with placebo

Patients reporting treatment success5

68% with stem cells
53% with placebo
Sources: Kim 2023, phase III trial of 261 people with knee osteoarthritis; Cochrane review 2025, 25 trials with 1,341 people.

What improves

  • Wharton’s jelly stem cells. In a randomised trial, two injections of Wharton’s jelly stem cells gave a total WOMAC score of 4.2 after 12 months, against 15.2 with hyaluronic acid (lower is better).4 With two ultrasound-guided injections, patients with advanced knee arthritis had better pain and function scores at 12 and 48 months.12 A review of Wharton’s jelly studies found clear gains in pain and function.9 At Erciyes University in Turkey, cartilage thickness on MRI increased after treatment.13
  • Two years and longer. In a placebo-controlled trial of 146 patients, a single stem cell injection improved knee scores for two years and protected cartilage on MRI.23 Other studies measured benefit for four and five years.1415
  • Better than hyaluronic acid. A 2025 analysis of 10 randomised trials with 818 patients found that stem cell injections improved knee pain and function more than hyaluronic acid at 12 months.6 Other meta-analyses confirmed better function at 6 and 12 months.710
  • Umbilical cord cells. In a review of 36 randomised trials, umbilical cord stem cells gave the largest pain relief of all cell sources.11 A review of 8 umbilical cord studies with 688 participants found better knee scores at six months than with control treatments.21
  • The overall picture. The 2025 Cochrane review found that stem cell injections may improve knee pain and function compared with placebo, and 68% of treated patients reported success.5

Hip arthritis

Studies of stem cell injections for hip arthritis report pain reductions of around 30 to 50% and better hip function.2829 In a 15-year study of 434 hips, people treated with bone marrow cell concentrate needed a hip replacement far less often: 16% against 40% with usual care.30

Rheumatoid arthritis

  • In 172 people with active rheumatoid arthritis, adding umbilical cord stem cell infusions to standard medication improved disease activity and lowered TNF-α and IL-6.22
  • In a randomised trial of 105 patients, 54% had a good or moderate response at 12 weeks, and the effect lasted 48 weeks without repeat dosing.23
  • Disease activity stayed lower at one and three years,25 the benefit was maintained through at least five years,24 and in another trial 53% reached a 20% improvement in symptoms within three months.26
  • Stem cells injected into the knee of people with rheumatoid arthritis improved pain, stiffness and pain-free walking distance.27

Exosomes

Early clinical studies of umbilical cord exosomes in knee arthritis report good tolerability and meaningful improvements in pain and function, with two in three patients responding.3132

05

Your results timeline

In trials, pain and function improved from three months,20 with clear gains at six months1 that continued at 12 months.42 Long-term studies measured benefit for two to five years.31415 We review your progress with you at about 1, 3, 6 and 12 months.

  1. 3 monthsLess painPain and function improve
  2. 6 monthsEasier movementClear gains in clinical trials
  3. 12 monthsGains holdBenefit still measured at one year
  4. 2–5 yearsLasting benefitMeasured in long-term studies
  5. Second doseBest resultsA second dose at six months

06

Who stem cell therapy for arthritis helps

Stem cell therapy is suitable for many people with joint pain from arthritis. It gives the best results when cartilage is still present, so the earlier you start, the more there is to protect: in an exosome study, 83% of people with mild knee arthritis and 67% with moderate knee arthritis responded.32

  • Knee osteoarthritis, the condition studied most.124
  • Hip osteoarthritis and other joints.2829
  • Rheumatoid arthritis, alongside your usual medication.2224
  • People who want to avoid or delay joint replacement.330

Every patient is assessed by our specialist first, so your plan is built around your joints, your health and your goals.

A smiling couple in their sixties walks up an old sunlit stone staircase between colourful houses in Istanbul

07

Safety and comfort

The published safety record is reassuring. In the phase III trial there were no serious treatment-related side effects,1 and in the 146-patient trial the only effects were some swelling or soreness at the injection site that settled within days.2 Serious side effects were no more frequent than with placebo,5 and reviews found no increase in side effects compared with control treatments.711 Across studies of Wharton’s jelly stem cells, there were no serious side effects,9 and people with rheumatoid arthritis followed for five years had no increase in side effects over time.24

The injection is minimally invasive and given under sterile conditions, and you walk out of the clinic the same day.

08

Stem cell therapy for arthritis cost in Turkey: what’s included

Your price depends on the number of joints treated, the number of stem cells and whether your plan includes a second dose. After your free medical review you receive a fixed, all-inclusive price in writing, before you book anything.

Included

  • Free medical review and phone consultation
  • Fresh Wharton’s jelly stem cells, with certified count and viability
  • Treatment by our specialist
  • Ground transport to and from the clinic
  • A personal case manager
  • Aftercare and follow-up reviews

Not included / optional

  • Flights
  • Hotel stay, which we can arrange for you
  • A second dose, if it is part of your plan

Read why patients choose Turkey for stem cell therapy.

09

Our guarantees to you

  • A fixed price in writingYour all-inclusive price is confirmed in writing before you travel. No surprises.
  • A guaranteed cell countThe number of fresh stem cells in your plan is guaranteed, and the count and viability are checked and certified by our GMP laboratory before treatment.
  • Follow-up includedProgress reviews at about 1, 3, 6 and 12 months are part of every treatment.
  • A free consultation with Dr. Cihan BolatBefore you commit, our medical director reviews your case free of charge.

10

Your stem cell arthritis treatment in Istanbul, step by step

  1. Free medical review

    Tell us your age, which joints are affected and which treatments you have tried, and send your recent X-rays, MRI or blood tests. Our specialist reviews your case.

  2. Free phone consultation and fixed price

    Once your case is approved, you discuss your plan with the specialist and receive the total price in writing.

  3. Fresh preparation

    After your deposit, your stem cells are prepared fresh for your date. Preparation usually takes 5 to 10 days.

  4. Treatment day

    Our driver takes you to the clinic, where the specialist gives your treatment, and brings you back afterwards.

  5. Home and follow-up

    We review your progress with you at about 1, 3, 6 and 12 months and plan a second dose with you if it is part of your plan.

Read more about the treatment process step by step.

11

Why patients choose Istanbul Stemcell for stem cell therapy for arthritis in Turkey

Led by Dr. Cihan Bolat

Our medical director is a specialist in anaesthesiology and reanimation and in regenerative medicine, and leads every treatment.

Fresh cells, licensed laboratory

Fresh Wharton’s jelly stem cells from a Ministry of Health-approved, GMP-certified laboratory, never frozen.

Specialist-led

Every treatment is assessed and given by specialists trained in the United States and Turkey, not by general practitioners.

Non-surgical, one day

No operation and no hospital stay: one treatment day, with transport to and from the clinic included.

12

Frequently asked questions

Does stem cell therapy work for knee arthritis?

Yes, in randomised trials stem cell injections reduced knee pain and improved function more than placebo or hyaluronic acid. In a 261-patient phase III trial, a single injection improved pain by 25.2 points against 15.5 with placebo on a 100-point scale.

What is the success rate of stem cell injections for knees?

In the 2025 Cochrane review of 25 trials, 68% of patients treated with stem cells reported treatment success, against 53% with placebo. In an exosome study, 83% of people with mild knee arthritis responded.

How long does stem cell therapy last in the knee?

In clinical trials, benefits lasted 12 to 24 months after a single treatment, and long-term studies measured benefit for four and five years. A second dose can build on your result.

How much does stem cell therapy for knees cost in Turkey?

Your price depends on the number of joints, the number of stem cells and whether your plan includes a second dose. After a free medical review you receive a fixed, all-inclusive price in writing, which includes the treatment by our specialist, fresh Wharton’s jelly stem cells, ground transport, a personal case manager and follow-up reviews.

Can stem cells help me avoid knee replacement?

Stem cell therapy is a non-surgical option to try before surgery. In a two-year placebo-controlled trial, 1 patient treated with stem cells needed a knee replacement against 4 with placebo, and in a 15-year hip study, 16% needed a hip replacement against 40% with usual care.

Can stem cells regrow cartilage in the knee?

Stem cells help protect and support cartilage. In a two-year placebo-controlled trial, cartilage quality on MRI did not worsen with stem cells while it gradually worsened with placebo, and some studies measured thicker cartilage after treatment.

How long does it take for stem cells to work in the knee?

In clinical trials, pain and function improved from three months, with clear gains at six months that continued at 12 months.

How many stem cell injections are needed for the knee?

One treatment day is the start. In the Wharton’s jelly trial, a second dose at six months gave the best results, and a review of 16 trials found that repeat injections improved pain and function more than a single one.

Are stem cell knee injections painful? What are the side effects?

The injection is minimally invasive and given under sterile conditions. In the large trials there were no serious treatment-related side effects; some people had swelling or soreness at the injection site that settled within days.

Can stem cell therapy help rheumatoid arthritis?

Yes. In 172 people with active rheumatoid arthritis, umbilical cord stem cell infusions added to standard medication improved disease activity and lowered inflammation, and in long-term follow-up the benefit was maintained through at least five years.

Is stem cell therapy for rheumatoid arthritis given by IV or into the joint?

Most rheumatoid arthritis studies gave umbilical cord stem cells by IV drip, alongside the usual medication. Stem cells injected into the knee also improved pain and stiffness in people with rheumatoid arthritis. Dr. Cihan Bolat plans the right route for your joints.

What are Wharton’s jelly stem cells, and are they safe?

Wharton’s jelly is the soft tissue of the umbilical cord, collected from cords donated after healthy births. Its stem cells are young, need no donor matching, and in studies of Wharton’s jelly stem cells for knee arthritis there were no serious side effects.

What are exosomes, and can they help arthritis?

Exosomes are tiny packages of the stem cells’ signals, with no living cells inside. Early clinical studies of umbilical cord exosomes in knee arthritis report good tolerability and meaningful improvements in pain and function.

Who is a good candidate for stem cell therapy for arthritis?

People with knee or hip osteoarthritis or rheumatoid arthritis who want less pain and better movement without surgery. Results are best when cartilage is still present, so mild and moderate arthritis respond best. Our specialist reviews your X-rays or MRI first.

Does stem cell therapy work for hip arthritis?

Studies of stem cell injections for hip arthritis report pain reductions of around 30 to 50% and better hip function, with only rare, mild side effects.

How long do I need to stay in Istanbul?

The treatment itself takes one day, and our driver takes you to and from the clinic. Many patients combine it with a short stay in Istanbul; we can arrange your hotel as part of your package.

Uzm. Dr. Cihan Bolat

Medical review

Uzm. Dr. Cihan Bolat
Medical Director, Istanbul Stemcell

This page was written from the published studies listed below and reviewed for medical accuracy on .

13

References

  1. Kim KI, et al. Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial. Am J Sports Med. 2023;51(9):2243-2253. PMID 37345256
  2. Gupta PK, et al. Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study. Am J Sports Med. 2023;51(9):2254-2266. PMID 37366164
  3. Gupta PK, et al. Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study. Osteoarthr Cartil Open. 2026;8(1):100723. PMID 41536418
  4. Matas J, et al. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Transl Med. 2019;8(3):215-224. PMID 30592390
  5. Whittle SL, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database Syst Rev. 2025;4(4):CD013342. PMID 40169165
  6. Jin WS, et al. Mesenchymal Stem Cells Injection Is More Effective Than Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis With Similar Safety: A Systematic Review and Meta-analysis. Arthroscopy. 2025;41(2):318-332. PMID 39154667
  7. Cao M, et al. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2025;16(1):122. PMID 40055739
  8. Deng L, et al. Efficacy and safety of single versus repeated injections of mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2025;16(1):505. PMID 41013772
  9. Ishak-Samrin M, et al. Treatment of Knee Osteoarthritis and Chondral Injury with Umbilical Cord/Wharton's Jelly-Derived Mesenchymal Stem Cells: A Systematic Review of Safety and Efficacy. J Funct Biomater. 2025;16(3). PMID 40137363
  10. Xiao Z, et al. Effects of the umbilical cord mesenchymal stem cells in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Medicine (Baltimore). 2024;103(46):e40490. PMID 39560593
  11. Zeng L, et al. Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: A systematic review and meta-analysis of 36 randomized controlled trials. Semin Arthritis Rheum. 2024;68:152498. PMID 38970896
  12. Samara O, et al. Ultrasound-guided intra-articular injection of expanded umbilical cord mesenchymal stem cells in knee osteoarthritis: a safety/efficacy study with MRI data. Regen Med. 2022;17(5):299-312. PMID 35546314
  13. Günay AE, et al. Assessment of clinical, biochemical, and radiological outcomes following intra-articular injection of Wharton jelly-derived mesenchymal stromal cells in patients with knee osteoarthritis: A prospective clinical study. Medicine (Baltimore). 2022;101(37):e30628. PMID 36123928
  14. Lamo-Espinosa JM, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II). J Transl Med. 2018;16(1):213. PMID 30064455
  15. Kim KI, et al. Safety and Efficacy of the Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritic Knee: A 5-Year Follow-up Study. Stem Cells Transl Med. 2022;11(6):586-596. PMID 35567774
  16. Vega A, et al. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015;99(8):1681-90. PMID 25822648
  17. Chahal J, et al. Bone Marrow Mesenchymal Stromal Cell Treatment in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial Inflammation. Stem Cells Transl Med. 2019;8(8):746-757. PMID 30964245
  18. Sadri B, et al. Cartilage regeneration and inflammation modulation in knee osteoarthritis following injection of allogeneic adipose-derived mesenchymal stromal cells: a phase II, triple-blinded, placebo controlled, randomized trial. Stem Cell Res Ther. 2023;14(1):162. PMID 37316949
  19. Tong W, et al. Intra-articular injection of umbilical cord-derived mesenchymal stem cells is safe and effective for moderate to severe knee osteoarthritis with synovitis: a double‑blinded and randomized controlled trial. BMC Musculoskelet Disord. 2025;27(1):84. PMID 41466394
  20. Matas J, et al. A Phase I Dose-Escalation Clinical Trial to Assess the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stromal Cells in Knee Osteoarthritis. Stem Cells Transl Med. 2024;13(3):193-203. PMID 38366909
  21. Lohrasbi E, et al. Regenerative Therapy in Osteoarthritis Using Umbilical Cord-Origin Mesenchymal Stem Cells: A Critical Appraisal of Clinical Safety and Efficacy Through Systematic Review and Meta-Analysis. Stem Cells Int. 2025;2025:4261166. PMID 41378180
  22. Wang L, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192-202. PMID 23941289
  23. Yang Y, et al. Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J Transl Med. 2018;16(1):165. PMID 29903026
  24. Yang Y, et al. Mesenchymal stem cells combined with IFN-γ treatment versus mesenchymal stem cells monotherapy: safety and efficacy over five years extension follow-up. Stem Cell Res Ther. 2025;16(1):642. PMID 41250139
  25. Wang L, et al. Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study. Drug Des Devel Ther. 2019;13:4331-4340. PMID 31908418
  26. He X, et al. Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis. Ann Rheum Dis. 2020;79(10):1298-1304. PMID 32561603
  27. Shadmanfar S, et al. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018;20(4):499-506. PMID 29428486
  28. E Reali G, Araujo Fernandes D, Campos Martins E. Outcomes Following Stem Cell-Based Therapies for Hip Osteoarthritis: A Scoping Review. Cureus. 2025;17(11):e96419. PMID 41376753
  29. Giorgino R, et al. Management of hip osteoarthritis: harnessing the potential of mesenchymal stem cells-a systematic review. Eur J Orthop Surg Traumatol. 2024;34(8):3847-3857. PMID 39254726
  30. Hernigou P, et al. Intraosseous bone marrow concentrate delays total hip arthroplasty in osteoarthritis: A fifteen year matched cohort study with dose-response analysis. Int Orthop. 2026;50(7):1617-1626. PMID 42301272
  31. Wang Y, et al. Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research. J Transl Med. 2025;23(1):641. PMID 40500748
  32. Yokota N, Kambayashi T, Tanabe Y. Safety and Efficacy of Intra-Articular Injection of Umbilical Cord-Derived Extracellular Vesicles in Patients With Knee Osteoarthritis: A Retrospective Study. Orthopedics. 2026;49(4):e351-e358. PMID 42611014
  33. Mancuso P, et al. Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome. Front Bioeng Biotechnol. 2019;7:9. PMID 30761298
  34. Kwon DG, et al. State of the Art: The Immunomodulatory Role of MSCs for Osteoarthritis. Int J Mol Sci. 2022;23(3). PMID 35163541
  35. Harrell CR, et al. Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed Pharmacother. 2019;109:2318-2326. PMID 30551490
  36. Almahasneh F, Abu-El-Rub E, Khasawneh RR. Mechanisms of analgesic effect of mesenchymal stem cells in osteoarthritis pain. World J Stem Cells. 2023;15(4):196-208. PMID 37181003
  37. Zhang S, et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16-27. PMID 29182933
  38. Figueroa-Valdés AI, et al. Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis. J Nanobiotechnology. 2025;23(1):13. PMID 39806427

Move more freely,
without surgery.

Tell us which joints hurt and send your X-rays or MRI, and we will send you a personal plan and a fixed price.

Request a free consultation
WhatsApp